ONPH
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | 0.00 | $0 | — |
| 2022 Q3 | -0.01 | $0 | -$1,984 |
| 2022 Q2 | -0.15 | $0 | -$3,600 |
| 2022 Q1 | -0.00 | $0 | $17,218 |
| 2004 Q3 | -40500.00 | $0 | -$81,000 |
| 2004 Q2 | -7500.00 | $0 | -$1,000 |
| 2004 Q1 | -89000.00 | $0 | -$88,000 |
| 2004 Q4 | -116500.00 | $94,000 | -$598,000 |